An observational study in Obstructive Sleep Apnea, sponsored by Acurable Ltd.. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2020-12-04.
Sponsored by Acurable Ltd. · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Sleep Apnea, Obstructive with a site in United Kingdom — 9 open to participants now, 13 under way, none of them phase 3. Sleep Apnea, Obstructive · United Kingdom.
Among the 54 studies in Sleep Apnea, Obstructive with a site in United Kingdom, this one is the 11th largest by enrollment of the 28 observational ones that give a count, is one of 6 that started in 2018, is one of 28 observational ones, and was the 25th registered.
2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.
Browse Sleep Apnea, Obstructive studies →9 of the 54 studies in Sleep Apnea, Obstructive with a site in United Kingdom are open now. Recruiting first, the newest first:
Virginia Hawkins · Sites in United Kingdom
Ages 18+
Inspire Medical Systems, Inc. · Sites in United Kingdom, Austria, Belgium and 4 more countries
Ages 18+
University College, London · Sites in United Kingdom
Ages 18+ · Healthy volunteers
Children's Health Ireland · Sites in United Kingdom, Ireland
Ages 6 mo–16 yrs
Royal Free Hospital NHS Foundation Trust · Sites in United Kingdom
Ages 18–80
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 3 · Phase 4 1
First in 2005; this study’s year is marked. 6 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 150 is above the median of 105 across 668 observational studies indexed under Sleep Apnea, Obstructive.
Median enrollment 58 across the 26 interventional studies, 102 across the 28 observational. Of the 36 that completed or were terminated, 4 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 54 have an industry lead sponsor. The 10 most frequent:
Acurable Ltd. is the lead sponsor of 5 studies on the registry; 3 are open to participants now.
Acurable Ltd. has 2 studies filed under Sleep Apnea, Obstructive — fewer than ten, so there is no comparison to draw.
2 of the studies in Sleep Apnea, Obstructive with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07497412King's College LondonThe Effect of Continuous Positive Airway Therapy on the Blood Pressure in Sleepy vs Non-sleepy Patients With Obstructive Sleep Apnea | 2026-11 |
| NCT06030349Children's Health IrelandClinical Outcomes From Treatment and Evaluation of Obstructive Sleep Apnoea in Children With Down Syndrome | 2027-11-28 |
Add all 2 to your calendar (.ics) → With an account.
Among the 54 studies in Sleep Apnea, Obstructive with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The primary endpoint is to evaluate the sensitivities and specificities for diagnosis of sleep apnoea of a wearable sleep diagnosis technology vs. existing gold standard.
The clinical investigation will be performed at the Royal Free London Hospital. Physiological signals will be pseudo-anonymized and only viewed by the research team.
The Study will involve patients who will have been referred for diagnosis of sleep apnoea, will aim to determine AcuPebble's positive and negative predictive ratios, sensitivities as specificities. Likelihood ratios for diagnosis of sleep apnoea. Clinical experts will determine patients' diagnostic information using the current diagnostic standards. AcuPebble will also generate diagnostic results independently and automatically. Both set of results will be subsequently compared and the relevant performance metrics listed above will be determined.
Consecutive patients referred for sleep study will be recruited to the study. Patients that are willing to participate will be consented on the day of their sleep study and sent home with both - the Trusts usual multichannel polygraphy and the Acupebble.
Patients who have been referred to a sleep clinic due to suspicion of sleep apnoea, consecutive 160 patients coming to the clinic.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
First group is the first 10 patients
following 150 patients
Sensitivities and Specificities for diagnosis of sleep apnoea studies
Sensitivities and Specificities for diagnosis of sleep apnoea studies
Time frame: 6 months
Plan to share: No
Ran from Jul 2018 to primary completion in Dec 2019, 17 months.
Of 36 industry-sponsored observational studies under Sleep Apnea, Obstructive, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 93. This study's 17 months is close to that.
Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 14 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Acurable Ltd.